Search Results
GDC-0973 5mg 5mg | Purity Not Available
Adooq Bioscience
GDC-0973, a selective inhibitor of MEK, also known as mitogen activated protein kinase kinase (MAPKK), is a key component of the RAS/RAF/MEK/ERK pathway, which is frequently activated in human tumors.
More Information Supplier PageGDC-0973 25mg 25mg | Purity Not Available
Adooq Bioscience
GDC-0973, a selective inhibitor of MEK, also known as mitogen activated protein kinase kinase (MAPKK), is a key component of the RAS/RAF/MEK/ERK pathway, which is frequently activated in human tumors.
More Information Supplier PageGDC-0973 10mg 10mg | Purity Not Available
Adooq Bioscience
GDC-0973, a selective inhibitor of MEK, also known as mitogen activated protein kinase kinase (MAPKK), is a key component of the RAS/RAF/MEK/ERK pathway, which is frequently activated in human tumors.
More Information Supplier PageGSK-923295 50mg 50mg | Purity Not Available
Adooq Bioscience
GSK-923295, is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E, (CENP-E).
More Information Supplier PageGSK-923295 5mg 5mg | Purity Not Available
Adooq Bioscience
GSK-923295, is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E, (CENP-E).
More Information Supplier PageGSK-923295 25mg 25mg | Purity Not Available
Adooq Bioscience
GSK-923295, is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E, (CENP-E).
More Information Supplier PageGSK-923295 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
GSK-923295, is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E, (CENP-E).
More Information Supplier PageGSK-923295 10mg 10mg | Purity Not Available
Adooq Bioscience
GSK-923295, is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E, (CENP-E).
More Information Supplier PageFMK 50mg 50mg | Purity Not Available
Adooq Bioscience
FMK is potent, highly specific and irreversible inhibitor of p90 ribosomal protein S6 kinase RSK1 and RSK2; Fmk binds in the CTKD ATP-binding site and inhibits RSK autophosphorylation at Ser386. Fmk induces significant apoptosis in human FGFR3-expressing, t(4;14)-positive multiple myeloma cells.
More Information Supplier Page